Proline-rich transmembrane protein 4 (PRRT4)

Proline-rich transmembrane protein 4 (PRRT4) is a predicted protein encoded by the human PRRT4 gene, classified as a protein-coding gene[3]. Limited functional data are available for PRRT4. It is predicted to be a membrane protein, but unlike some other members of the proline-rich transmembrane family (such as SynDIG4/PRRT1), there is as yet no substantive evidence that PRRT4 acts as a receptor, transporter, enzyme, or established therapeutic target. There is also no established role for PRRT4 in human disease, biological pathways, or pharmacological intervention, and no interacting drugs or mechanisms of action are documented[3]. PRRT4 is primarily identified through bioinformatic annotation, and its molecular and biological roles remain uncharacterized. Key considerations: - The target name is valid, but current literature and genetic databases do not assign this protein a defined function or therapeutic relevance[3]. - PRRT4 should not be confused with SynDIG4/PRRT1, which is an auxiliary protein for AMPA receptors[1]. There is no evidence that PRRT4 functions in similar pathways or molecular complexes. Reason for "is_incorrect: true": - Although PRRT4 is a real gene/protein, it is currently not considered a known or plausible drug target, and its molecular functions, biological pathways, and disease associations are essentially uncharacterized in scientific databases and the literature[3]. - If targeting information for PRRT4 is requested, the absence of data means this entry should be flagged as incomplete or unsupported.

Other names

PRRT4